12/03/2015 - 9:51am

In 2014, national health care spending grew at a rate of 5.3% — a marked increase over the 2.9% growth seen in 2013, and an increase of the past five years, which averaged 3.7% growth.

12/02/2015 - 3:45pm

According to an Associated Press report published in the New York Times, a bipartisan Senate Finance committee report found that Gilead Sciences, maker of hepatitis C treatments Harvoni and Sovaldi, chose to price Sovaldi at $1,000 a pill ($84,000 for a course of treatment) despite evidence that a lower price would allow more people to take advantage of the treatment. Gilead rejected the committee’s conclusions, noting that it “responsibly and thoughtfully priced Sovaldi and Harvoni,” as lawmakers point to this case as a cautionary tale for other expensive treatments. (New York Times)

12/01/2015 - 4:24pm

GPhA’s SVP sciences and regulatory affairs noted that GPhA and other industry associations have urged the FDA to avoid ambiguity in quality metrics and consider additional moves that would ensure that proposed changes won’t disrupt supply.

11/20/2015 - 3:55pm

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

11/20/2015 - 11:57am

The Food and Drug Administration on Monday issued new warning labeling guidance for medicines containing acetaminophen, according to a blog posted by the Regulatory Affairs Professionals Society. "The guidance ... helps to clarify certain cases where manufacturers of internal analgesic, antipyretic and antirheumatic OTC drugs would be able to change liver warnings when the product's directions for use result in a maximum daily dose of acetaminophen that is less than 4,000 mg for adults," wrote Zachary Brennan. (RAPS

 

11/19/2015 - 4:15pm

With the 17th Annual NACDS Foundation Dinner rapidly approaching, the publicity surrounding the 2015 Get Smart About Antibiotics Week provides a timely demonstration of the public health relevance that the NACDS Foundation's benefactors will support on Dec. 3. 

11/18/2015 - 11:27am

Read about 8 of the various civil cases that the Department of Justice and Federal Trade Commission have brought against supplement makers or individuals. 

11/18/2015 - 8:46am

The Department of Justice announced the indictment of more than 100 manufacturers of illegal supplements as part of a yearlong effort that began last November. 

11/12/2015 - 4:42pm

CQ Roll Call profiled NACDS’ VP government affairs in a piece ahead of the Nov. 16 ceremony for the Professional Women in Advocacy Conference’s Excellence in Advocacy award, for which Kelly is a finalist.